Irritable bowel syndrome Survey in gastroenterological adult outpatients in China

Trial Identifier: D1844R00004
Sponsor: AstraZeneca
NCTID:: NCT02955316
Start Date: February 2017
Primary Completion Date: September 2017
Study Completion Date: September 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations